Targeting INflammation Using SALsalate in Type 2 Diabetes (TINSAL-T2D)

NCT00392678 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

277

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: Salsalate
DRUG: Placebo

Sponsor

Joslin Diabetes Center

Collaborators

[object Object]